Therapeutic Areas

Swixx BioPharma’s focus is in 4 strategic therapeutic areas, launching highly innovative, new therapies in Rare disease, Oncology/Hematology, Specialty Care and Vaccines.

Swixx also commercializes multiple Consumer Healthcare products via a dedicated CHC Business Unit in a limited territory - the Baltics, West Balkans and Russia.

Rare Disease

Despite the rarity of each disease, rare diseases affect many patients worldwide.

Read more


Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020.

Read more

Specialty Care

Chronic diseases are the leading causes of death and disability worldwide.

Read more


Vaccination is one of the greatest achievements of the 20th century that reduces the burden of infectious diseases immediately after broad access to clean water.

Read more
  • BluePrint
  • Jazz Pharmaceuticals
  • Norgine
  • SeaGen
  • Otsuka
  • Bristol Myers
  • Sanofi
  • UPSA
  • GE Healthcare
  • Vifor
  • Gilead
  • Amgen
  • Alcon
  • Merz
  • Astra Zeneca
  • Kyowa Kirin
  • Fresenius
  • PTC
  • BeiGene
  • Incyte
  • BioCryst
  • Eli Lilly
  • OM Pharma
  • Pharmanutra
  • Y-mAbs


Corporate Headquarters

Swixx Biopharma AG
Phone: +41 41 5523 440
Address: Neuhofstrasse 5A, CH-6340 Baar

Other Countries

Management Center

Swixx Biopharma AG, branch
Phone: +420 242 434 242
Address: Hybernská 5, 11000 Praha 1
Czech Republic